Aspocomp’s financial reporting and Annual General Meeting in 2023
Aspocomp Group Plc, Stock Exchange Release, November 9, 2022 at 4:10 p.m. EET
Aspocomp Group Plc will publish its financial information in 2023 as follows:
Financial Statements 2022: Thursday, March 16, 2023 at around 9:00 a.m. EET
Interim Report January-March, 2023: Thursday, April 20, 2023 at around 8:00 a.m. EEST
Half-year Report January-June, 2023: Thursday, July 20, 2023 at around 9:00 EEST
Interim Report January-September, 2023: Thursday, November 9, 2023 at around 9:00 EET
Aspocomp's silent period commences 30 days prior to the publication of its financial information.
Annual Report 2022
Annual Report 2022 will be published on Tuesday, March 28, 2023. Annual Report contains Financial Statements, the report of the Board of Directors and Auditor’s Report.
Annual General Meeting 2023
Aspocomp’s Annual General Meeting 2023 is scheduled for Thursday, April 20 at 10:00 a.m. EEST. The meeting will be convened by the company’s Board of Directors later on.
Shareholders, who wish to have an issue on the agenda of the AGM, shall notify the company’s Board of Directors in writing on Friday, January 27, 2023, at the latest by mail to address Aspocomp Group Plc., AGM, Keilaranta 1, 02150 Espoo, Finland or by email to yhtiokokous(at)aspocomp.com.
For further information, please contact Mikko Montonen, CEO,
tel. +358 20 775 6860, mikko.montonen(at)aspocomp.com.
ASPOCOMP GROUP PLC
Mikko Montonen
President and CEO
Aspocomp – heart of your technology
A printed circuit board (PCB) is used for electrical interconnection and as a component assembly platform in electronic devices. Aspocomp provides PCB technology design, testing and logistics services over the entire lifecycle of a product. The company’s own production and extensive international partner network guarantee cost-effectiveness and reliable deliveries.
Aspocomp’s customers are companies that design and manufacture telecommunication systems and equipment, automotive and industrial electronics, and systems for testing semiconductor components for security technology. The company has customers around the world and most of its net sales are generated by exports.
Aspocomp is headquartered in Espoo and its plant is in Oulu, one of Finland’s major technology hubs.
www.aspocomp.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Completion of capital reduction in Spar Nord Bank A/S26.4.2024 08:45:00 CEST | Press release
Company announcement no. 28 As stated in company announcement no. 22, it was decided at Spar Nord Bank A/S’ ordinary general meeting on 19 March 2024 to reduce the company’s share capital by DKK 27,645,950 nominal value divided into 2,764,595 shares of DKK 10 through the cancellation of treasury shares. The capital reduction was published via the Danish Business Authority’s IT system on 26 March 2024. The statutory notice period has expired with no claims received. The capital reduction has been finally registered with the Danish Business Authority on 25 April 2024. After the capital reduction, the share capital of Spar Nord Bank A/S amounts to DKK 1,177,020,310 nominal value divided into shares of DKK 10 each. Pursuant to section 32 of the Danish Capital Markets Act, we hereby announce that the company’s total share capital and total number of voting rights amount to: Share capital (nominal value): DKK 1,177,020,310 Number of voting rights: 117,702,031 Please direct any questions rega
Gennemførelse af kapitalnedsættelse i Spar Nord Bank A/S26.4.2024 08:45:00 CEST | pressemeddelelse
Selskabsmeddelelse nr. 28 Som oplyst i selskabsmeddelelse nr. 22 blev det på Spar Nord Bank A/S’ ordinære generalforsamling den 19. marts 2024 besluttet at nedsætte selskabets aktiekapital med nominelt DKK 27.645.950 fordelt i 2.764.595 aktier à DKK 10 ved annullation af egne aktier. Offentliggørelse af kapitalnedsættelsen har fundet sted i Erhvervsstyrelsens it-system den 26. marts 2024. Proklamafristen er udløbet uden indsigelser. Kapitalnedsættelsen er endeligt registreret den 25. april 2024 hos Erhvervsstyrelsen. Efter kapitalnedsættelsen udgør aktiekapitalen i Spar Nord Bank A/S nominelt DKK 1.177.020.310 fordelt i aktier à DKK 10. I henhold til §32 i lov om kapitalmarkeder oplyses det hermed, at selskabets samlede aktiekapital og samlede antal stemmerettigheder er opgjort til: Aktiekapital (nominelt): DKK 1.177.020.310 Antal stemmerettigheder: 117.702.031 Spørgsmål i forbindelse med denne meddelelse kan rettes til undertegnede på 96 34 42 36. Venlig hilsen Rune Brandt Børglum IR-
Adevinta (ASA) publishes its 2023 Annual Report26.4.2024 08:30:00 CEST | Press release
Oslo, 26 April 2024 – Adevinta ASA today released its 2023 Annual Report, available here. A printed copy may be obtained free of charge upon written request to: ir@adevinta.com. Reflecting on 2023, Antoine Jouteau, CEO, said: “Over the past year, we have made significant progress on redesigning our operating model, verticalising our organisation in line with our Growing At Scale strategy and successfully completing our portfolio optimisation. We have achieved strong financial and operational performance in 2023 and continued to deliver against our targets, despite the tough macroeconomic environment. Following the divestment of our Hungarian classifieds business, our portfolio is now centred around our core European markets of France, Germany, Spain, Italy and Benelux, complemented by Canada and our joint ventures. We are delivering significant growth in our Mobility, Re-Commerce and Real Estate & Emerging verticals, substantiating our focus in these areas. By putting technology and pr
PCI Biotech Holding ASA - Annual Report 202326.4.2024 08:08:19 CEST | Press release
Oslo, Norway, April 26, 2024. The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2023. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2023 is also available on the company’s website www.pcibiotech.com. For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CEO, rs@pcibiotech.no, Mobile: +47 940 05 757 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachments 2023 Annual Report PCI Biotech Holding ASApcibiotechholdingasa-2023-12-31-en
Delårsrapport för januari – mars 202426.4.2024 08:00:00 CEST | Pressemelding
STOCKHOLM – den 26 april 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) publicerar idag sin delårsrapport för januari – mars 2024. Den fulla rapporten är tillgänglig på bolagets hemsida. ”Det har varit en stark inledning på 2024 där utvecklingen inom respektive portföljbolag löper enligt plan. Trots att vi haft ett motigt marknadsklimat har våra portföljbolag outtröttligt fortsatt driva utvecklingen av framtidens behandlingar vidare för att de så snabbt som möjligt ska komma patienterna till gagn. Vi ser fram emot tilltagande medvind och fler framsteg under året”, säger Viktor Drvota, VD, Karolinska Development. Väsentliga händelser under första kvartalet Portföljbolaget OssDsign rapporterade positiva data från den kliniska studien TOP FUSION. Top-line-resultaten, som granskats av oberoende radiologer, visar en fusionsgrad på 93 procent 12 månader efter operation med det nya nanosyntetiska bengraftet OssDsign Catalyst (januari 2024).Portföljbolaget AnaCardio erhöll SEK 50 mil